Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis

Terminated

Phase 3 Results N/A

Summary of Purpose

The purpose of the present prospective, randomized, double-blind, double dummy controlled multicenter pilot study is to investigate whether abciximab, compared with aspirin, is able to reduce the rate of recurrent ischemic strokes before and during carotid endarterectomy [CEA] (primary endpoints); and the degree of... Trial Stopped: Higher hemorrhage rates of Abciximab in ABESST II trial

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2007.

1 Apr 2004 29 Jul 2005 Unavailable 1 May 2005 1 May 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available